Pete Wishart.

What considerations have been given to extending the cut-off date for eligibility for the Unethical Research Award in the Infected Blood Compensation Scheme beyond 1984, given the evidence in the Infected Blood Inquiry (Additional Report on Compensation) that experimentation on both adults and children continued beyond this date.

The Inquiry, in its Additional Report, made a set of recommendations about the Unethical Research awards. The Government has consulted on these recommendations, including on a proposal to expand eligibility for Unethical Research awards to …read full →

If he will publish the grounds of justification for the reduction in hepatitis C Financial Loss Awards from 2017 due to the introduction of new effective treatments; and if he will make a statement.

The compensation scheme assumes that the introduction of effective treatments in 2016 improved most infected people’s ability to effectively manage their infection. This assumption is applied when calculating financial loss for living infec…read full →

What consideration is being given to altering the Hepatitis C Financial Loss Award to reflect people who received older and more harmful treatments; and if he will make a statement.

In its Additional Report, the Infected Blood Inquiry recommended changes to the infection severity bands to give greater recognition for the suffering caused particularly by interferon treatment. The Government agrees that changes are neede…read full →

What justification is being applied to changes to the Infected Blood Compensation Scheme, where individuals who suffered long-term health harms of interferon treatment are to receive an uplift in compensation from 2017 onwards rather than from when their treatment began.

The Inquiry recommended changes to the infection severity bands to give greater recognition for the suffering caused by interferon treatment. The Government agrees that changes are needed and we have consulted on our proposal to introduce a…read full →